Joshua Abram & Alan Murray

Over the past two decades Joshua and Alan have been founders and CEOs of a series of venture-backed companies which are recognized as category creators in diverse fields including technology, hospitality, and life sciences. Among these are Integral Ad Science (NASDAQ:IAS), NeueHouse, TMRW Life Sciences and Conceivable Life Sciences. As of December 2021, these firms had a market value of over $5 billion. In 2021 they were both named to Goldman Sach’ s “100 Most Intriguing Entrepreneurs” list.

The primary vehicle for the companies that Joshua and Alan start is Coriolis Ventures, their incubation fund. Through Coriolis, they act as both Founders and active seed-stage investors across multiple industries. Coriolis has provided the earliest capital to numerous successful startups that have exited through IPO and acquisitions to such firms as AT&T, Expedia and Greenthumb. 

Since 2018, Joshua and Alan have focused intensively on both founding and funding disruptive technology companies in the fertility space. In 2018 they created TMRW Life Sciences, the world’s only FDA vetted automated technology for the management of the frozen eggs and embryos. TMRW employs ~100 people and has secured more than $150M in financing from investors including Google Ventures, 5AM Ventures, Casdin Capital, Transformation Capital and Peter Thiel. Their additional investments in the fertility space includes artificial intelligence pacesetter IVF2.0 and AutoIVF, which is developing microfluidic automation for IVF.